Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Slawomir Majewski Insider Profile
4 Followers
Slawomir Majewski, European Director at Helix BioPharma, holds 1.71M shares in Helix BioPharma (Ticker: TSE:HBP). Most recently, Slawomir Majewski Sold C$209,900 shares of Helix BioPharma on Feb 13, 2014 for an estimated value of 388.31K.
Slawomir Majewski has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Slawomir Majewski's holdings
Insider Roles
European Director
Roles that Slawomir Majewski holds in companies
Most Profitable Insider Trade
The most profitable trade made by Slawomir Majewski
Slawomir Majewski's Trading History
List of latest transactions for each holding click on a transaction to see Slawomir Majewski's performance on stock
You May Also Like
Slawomir Majewski insider profile FAQ
What is the percentage of profitable transactions made by Slawomir Majewski?
The percentage of profitable transactions made by Slawomir Majewski is ―.
What is the average return per transaction made by Slawomir Majewski?
The average return per transaction made by Slawomir Majewski is ―.
What stocks does Slawomir Majewski hold?
Slawomir Majewski holds: TSE:HBP stocks.
What was Slawomir Majewski’s latest transaction?
Slawomir Majewski latest transaction was an Informative Sell of C$388.31K.
What was Slawomir Majewski's most profitable transaction?
Slawomir Majewski’s most profitable transaction was an Informative Sell of TSE:HBP stock on February 13, 2014. The return on the trade was -2.00%.
What is Slawomir Majewski's role in Helix BioPharma?
Slawomir Majewski's role in Helix BioPharma is European Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.